Global Adalimumab Biosimilar Market Analysis 2016-2020 and Forecast 2021-2026
SNAPSHOT
The global Adalimumab Biosimilar market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Adalimumab Biosimilar by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
The global Adalimumab Biosimilar market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Adalimumab Biosimilar by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
- Tablet
- Oral Solution
- AET BioTech
- Amgen
- Boehringer Ingelheim
- Coherus Biosciences
- Fujifilm Kyowa Kirin Biologics
- LG Life Sciences/Mochida Pharmaceutical
- Momenta Pharmaceuticals
- Oncobiologics
- Pfizer
- Samsung Bioepsis
- Sandoz
- Zydus Cadila
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
- Asia-Pacific (China, India, Japan, Southeast Asia etc.)
- South America (Brazil, Argentina etc.)
- Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW
1.1 Adalimumab Biosimilar Industry
Figure Adalimumab Biosimilar Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Adalimumab Biosimilar
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Adalimumab Biosimilar
1.2.2 Downstream
Table Application Segment of Adalimumab Biosimilar
Table Global Adalimumab Biosimilar Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 ADALIMUMAB BIOSIMILAR MARKET BY TYPE
3.1 By Type
3.1.1 Tablet
Table Major Company List of Tablet
3.1.2 Oral Solution
Table Major Company List of Oral Solution
3.2 Market Size
Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in USD Million
Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in USD Million
Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in Volume
Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in USD Million
Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 AET BioTech (Company Profile, Sales Data etc.)
4.1.1 AET BioTech Profile
Table AET BioTech Overview List
4.1.2 AET BioTech Products & Services
4.1.3 AET BioTech Business Operation Conditions
Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen (Company Profile, Sales Data etc.)
4.2.1 Amgen Profile
Table Amgen Overview List
4.2.2 Amgen Products & Services
4.2.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.3.2 Boehringer Ingelheim Products & Services
4.3.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Coherus Biosciences (Company Profile, Sales Data etc.)
4.4.1 Coherus Biosciences Profile
Table Coherus Biosciences Overview List
4.4.2 Coherus Biosciences Products & Services
4.4.3 Coherus Biosciences Business Operation Conditions
Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Fujifilm Kyowa Kirin Biologics (Company Profile, Sales Data etc.)
4.5.1 Fujifilm Kyowa Kirin Biologics Profile
Table Fujifilm Kyowa Kirin Biologics Overview List
4.5.2 Fujifilm Kyowa Kirin Biologics Products & Services
4.5.3 Fujifilm Kyowa Kirin Biologics Business Operation Conditions
Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 LG Life Sciences/Mochida Pharmaceutical (Company Profile, Sales Data etc.)
4.6.1 LG Life Sciences/Mochida Pharmaceutical Profile
Table LG Life Sciences/Mochida Pharmaceutical Overview List
4.6.2 LG Life Sciences/Mochida Pharmaceutical Products & Services
4.6.3 LG Life Sciences/Mochida Pharmaceutical Business Operation Conditions
Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Momenta Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Momenta Pharmaceuticals Profile
Table Momenta Pharmaceuticals Overview List
4.7.2 Momenta Pharmaceuticals Products & Services
4.7.3 Momenta Pharmaceuticals Business Operation Conditions
Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Oncobiologics (Company Profile, Sales Data etc.)
4.8.1 Oncobiologics Profile
Table Oncobiologics Overview List
4.8.2 Oncobiologics Products & Services
4.8.3 Oncobiologics Business Operation Conditions
Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Pfizer (Company Profile, Sales Data etc.)
4.9.1 Pfizer Profile
Table Pfizer Overview List
4.9.2 Pfizer Products & Services
4.9.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Samsung Bioepsis (Company Profile, Sales Data etc.)
4.10.1 Samsung Bioepsis Profile
Table Samsung Bioepsis Overview List
4.10.2 Samsung Bioepsis Products & Services
4.10.3 Samsung Bioepsis Business Operation Conditions
Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sandoz (Company Profile, Sales Data etc.)
4.11.1 Sandoz Profile
Table Sandoz Overview List
4.11.2 Sandoz Products & Services
4.11.3 Sandoz Business Operation Conditions
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Zydus Cadila (Company Profile, Sales Data etc.)
4.12.1 Zydus Cadila Profile
Table Zydus Cadila Overview List
4.12.2 Zydus Cadila Products & Services
4.12.3 Zydus Cadila Business Operation Conditions
Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Adalimumab Biosimilar Sales Revenue 2016-2020, by Company, in USD Million
Table Global Adalimumab Biosimilar Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Adalimumab Biosimilar Sales Revenue Share in 2020, by Company, in USD Million
Table Global Adalimumab Biosimilar Sales Volume 2016-2020, by Company, in Volume
Table Global Adalimumab Biosimilar Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Adalimumab Biosimilar Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Adalimumab Biosimilar Market Concentration, in 2020
Figure Europe Adalimumab Biosimilar Market Market Concentration, in 2020
Figure Asia-Pacific Adalimumab Biosimilar MMarket Concentration, in 2020
Figure South America Adalimumab Biosimilar Market Concentration, in 2020
Figure Middle East & Africa Adalimumab Biosimilar Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacy
Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacy
Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in Volume
6.1.3 Demand in Online Pharmacy
Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in USD Million
Figure Adalimumab Biosimilar Market Growth 2021-2026, by Application, in USD Million
Figure Adalimumab Biosimilar Market Share in 2026, by Application, in USD Million
Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in Volume
Table Adalimumab Biosimilar Market Growth 2021-2026, by Application, in Volume
Table Adalimumab Biosimilar Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Adalimumab Biosimilar Production 2016-2020, by Region, in USD Million
Table Adalimumab Biosimilar Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in USD Million
Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in USD Million
Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in Volume
Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in USD Million
Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
1.1 Adalimumab Biosimilar Industry
Figure Adalimumab Biosimilar Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Adalimumab Biosimilar
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Adalimumab Biosimilar
1.2.2 Downstream
Table Application Segment of Adalimumab Biosimilar
Table Global Adalimumab Biosimilar Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 ADALIMUMAB BIOSIMILAR MARKET BY TYPE
3.1 By Type
3.1.1 Tablet
Table Major Company List of Tablet
3.1.2 Oral Solution
Table Major Company List of Oral Solution
3.2 Market Size
Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in USD Million
Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in USD Million
Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in Volume
Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in USD Million
Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in Volume
4 MAJOR COMPANIES LIST
4.1 AET BioTech (Company Profile, Sales Data etc.)
4.1.1 AET BioTech Profile
Table AET BioTech Overview List
4.1.2 AET BioTech Products & Services
4.1.3 AET BioTech Business Operation Conditions
Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Amgen (Company Profile, Sales Data etc.)
4.2.1 Amgen Profile
Table Amgen Overview List
4.2.2 Amgen Products & Services
4.2.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Boehringer Ingelheim (Company Profile, Sales Data etc.)
4.3.1 Boehringer Ingelheim Profile
Table Boehringer Ingelheim Overview List
4.3.2 Boehringer Ingelheim Products & Services
4.3.3 Boehringer Ingelheim Business Operation Conditions
Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Coherus Biosciences (Company Profile, Sales Data etc.)
4.4.1 Coherus Biosciences Profile
Table Coherus Biosciences Overview List
4.4.2 Coherus Biosciences Products & Services
4.4.3 Coherus Biosciences Business Operation Conditions
Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Fujifilm Kyowa Kirin Biologics (Company Profile, Sales Data etc.)
4.5.1 Fujifilm Kyowa Kirin Biologics Profile
Table Fujifilm Kyowa Kirin Biologics Overview List
4.5.2 Fujifilm Kyowa Kirin Biologics Products & Services
4.5.3 Fujifilm Kyowa Kirin Biologics Business Operation Conditions
Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 LG Life Sciences/Mochida Pharmaceutical (Company Profile, Sales Data etc.)
4.6.1 LG Life Sciences/Mochida Pharmaceutical Profile
Table LG Life Sciences/Mochida Pharmaceutical Overview List
4.6.2 LG Life Sciences/Mochida Pharmaceutical Products & Services
4.6.3 LG Life Sciences/Mochida Pharmaceutical Business Operation Conditions
Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Momenta Pharmaceuticals (Company Profile, Sales Data etc.)
4.7.1 Momenta Pharmaceuticals Profile
Table Momenta Pharmaceuticals Overview List
4.7.2 Momenta Pharmaceuticals Products & Services
4.7.3 Momenta Pharmaceuticals Business Operation Conditions
Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Oncobiologics (Company Profile, Sales Data etc.)
4.8.1 Oncobiologics Profile
Table Oncobiologics Overview List
4.8.2 Oncobiologics Products & Services
4.8.3 Oncobiologics Business Operation Conditions
Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Pfizer (Company Profile, Sales Data etc.)
4.9.1 Pfizer Profile
Table Pfizer Overview List
4.9.2 Pfizer Products & Services
4.9.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Samsung Bioepsis (Company Profile, Sales Data etc.)
4.10.1 Samsung Bioepsis Profile
Table Samsung Bioepsis Overview List
4.10.2 Samsung Bioepsis Products & Services
4.10.3 Samsung Bioepsis Business Operation Conditions
Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sandoz (Company Profile, Sales Data etc.)
4.11.1 Sandoz Profile
Table Sandoz Overview List
4.11.2 Sandoz Products & Services
4.11.3 Sandoz Business Operation Conditions
Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Zydus Cadila (Company Profile, Sales Data etc.)
4.12.1 Zydus Cadila Profile
Table Zydus Cadila Overview List
4.12.2 Zydus Cadila Products & Services
4.12.3 Zydus Cadila Business Operation Conditions
Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)
5 MARKET COMPETITION
5.1 Company Competition
Table Global Adalimumab Biosimilar Sales Revenue 2016-2020, by Company, in USD Million
Table Global Adalimumab Biosimilar Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Adalimumab Biosimilar Sales Revenue Share in 2020, by Company, in USD Million
Table Global Adalimumab Biosimilar Sales Volume 2016-2020, by Company, in Volume
Table Global Adalimumab Biosimilar Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Adalimumab Biosimilar Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Adalimumab Biosimilar Market Concentration, in 2020
Figure Europe Adalimumab Biosimilar Market Market Concentration, in 2020
Figure Asia-Pacific Adalimumab Biosimilar MMarket Concentration, in 2020
Figure South America Adalimumab Biosimilar Market Concentration, in 2020
Figure Middle East & Africa Adalimumab Biosimilar Market Concentration, in 2020
6 DEMAND BY END MARKET
6.1 Demand Situation
6.1.1 Demand in Hospital Pharmacy
Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in Volume
6.1.2 Demand in Retail Pharmacy
Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in Volume
6.1.3 Demand in Online Pharmacy
Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in USD Million
Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in USD Million
Figure Adalimumab Biosimilar Market Growth 2021-2026, by Application, in USD Million
Figure Adalimumab Biosimilar Market Share in 2026, by Application, in USD Million
Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in Volume
Table Adalimumab Biosimilar Market Growth 2021-2026, by Application, in Volume
Table Adalimumab Biosimilar Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 REGION OPERATION
7.1 Regional Production
Table Adalimumab Biosimilar Production 2016-2020, by Region, in USD Million
Table Adalimumab Biosimilar Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in USD Million
Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in USD Million
Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in Volume
Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in USD Million
Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in Volume
8 MARKETING & PRICE
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Adalimumab Biosimilar
2. Table Application Segment of Adalimumab Biosimilar
3. Table Global Adalimumab Biosimilar Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Oral Solution
5. Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in USD Million
6. Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in Volume
7. Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in Volume
9. Table AET BioTech Overview List
10. Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table Amgen Overview List
12. Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Boehringer Ingelheim Overview List
14. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Coherus Biosciences Overview List
16. Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Fujifilm Kyowa Kirin Biologics Overview List
18. Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table LG Life Sciences/Mochida Pharmaceutical Overview List
20. Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Momenta Pharmaceuticals Overview List
22. Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Oncobiologics Overview List
24. Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Pfizer Overview List
26. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Samsung Bioepsis Overview List
28. Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Sandoz Overview List
30. Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Zydus Cadila Overview List
32. Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)
33. Table Global Adalimumab Biosimilar Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Adalimumab Biosimilar Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Adalimumab Biosimilar Sales Volume 2016-2020, by Company, in Volume
36. Table Global Adalimumab Biosimilar Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in USD Million
40. Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in Volume
41. Table Adalimumab Biosimilar Market Growth 2021-2026, by Application, in Volume
42. Table Adalimumab Biosimilar Market Share in 2026, by Application, in Volume
43. Table Adalimumab Biosimilar Production 2016-2020, by Region, in USD Million
44. Table Adalimumab Biosimilar Production 2016-2020, by Region, in Volume
45. Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in USD Million
46. Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in USD Million
47. Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in Volume
48. Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in Volume
49. Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
50. Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
51. Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
52. Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
55. Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
56. Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
59. Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in USD Million
60. Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List
1. Table Upstream Segment of Adalimumab Biosimilar
2. Table Application Segment of Adalimumab Biosimilar
3. Table Global Adalimumab Biosimilar Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Oral Solution
5. Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in USD Million
6. Table Global Adalimumab Biosimilar Market 2016-2020, by Type, in Volume
7. Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in USD Million
8. Table Global Adalimumab Biosimilar Market Forecast 2021-2026, by Type, in Volume
9. Table AET BioTech Overview List
10. Table Business Operation of AET BioTech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
11. Table Amgen Overview List
12. Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table Boehringer Ingelheim Overview List
14. Table Business Operation of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Coherus Biosciences Overview List
16. Table Business Operation of Coherus Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Fujifilm Kyowa Kirin Biologics Overview List
18. Table Business Operation of Fujifilm Kyowa Kirin Biologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table LG Life Sciences/Mochida Pharmaceutical Overview List
20. Table Business Operation of LG Life Sciences/Mochida Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Momenta Pharmaceuticals Overview List
22. Table Business Operation of Momenta Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Oncobiologics Overview List
24. Table Business Operation of Oncobiologics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Pfizer Overview List
26. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Samsung Bioepsis Overview List
28. Table Business Operation of Samsung Bioepsis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
29. Table Sandoz Overview List
30. Table Business Operation of Sandoz (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
31. Table Zydus Cadila Overview List
32. Table Business Operation of Zydus Cadila (Sales Revenue, Cost, Gross Margin)
33. Table Global Adalimumab Biosimilar Sales Revenue 2016-2020, by Company, in USD Million
34. Table Global Adalimumab Biosimilar Sales Revenue Share 2016-2020, by Company, in USD Million
35. Table Global Adalimumab Biosimilar Sales Volume 2016-2020, by Company, in Volume
36. Table Global Adalimumab Biosimilar Sales Volume Share 2016-2020, by Company, in Volume
37. Table Regional Demand Comparison List
38. Table Major Application in Different Regions
39. Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in USD Million
40. Table Adalimumab Biosimilar Demand Forecast 2021-2026, by Application, in Volume
41. Table Adalimumab Biosimilar Market Growth 2021-2026, by Application, in Volume
42. Table Adalimumab Biosimilar Market Share in 2026, by Application, in Volume
43. Table Adalimumab Biosimilar Production 2016-2020, by Region, in USD Million
44. Table Adalimumab Biosimilar Production 2016-2020, by Region, in Volume
45. Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in USD Million
46. Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in USD Million
47. Table Global Adalimumab Biosimilar Market 2016-2020, by Region, in Volume
48. Table Global Adalimumab Biosimilar Market Share 2016-2020, by Region, in Volume
49. Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
50. Table North America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
51. Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
52. Table Europe Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
53. Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
54. Table Asia-Pacific Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
55. Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
56. Table South America Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
57. Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in USD Million
58. Table Middle East & Africa Adalimumab Biosimilar Market Size 2016-2020, by Country, in Volume
59. Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in USD Million
60. Table Adalimumab Biosimilar Market Forecast 2021-2026, by Region, in Volume
61. Table Price Factors List
LIST OF FIGURES
1. Figure Adalimumab Biosimilar Industry Chain Structure
2. Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in Volume
4. Figure Global Adalimumab Biosimilar Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Adalimumab Biosimilar Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Adalimumab Biosimilar Market Concentration, in 2020
7. Figure Europe Adalimumab Biosimilar Market Market Concentration, in 2020
8. Figure Asia-Pacific Adalimumab Biosimilar MMarket Concentration, in 2020
9. Figure South America Adalimumab Biosimilar Market Concentration, in 2020
10. Figure Middle East & Africa Adalimumab Biosimilar Market Concentration, in 2020
11. Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in USD Million
12. Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in Volume
13. Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in USD Million
14. Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in Volume
15. Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in USD Million
16. Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in Volume
17. Figure Adalimumab Biosimilar Market Growth 2021-2026, by Application, in USD Million
18. Figure Adalimumab Biosimilar Market Share in 2026, by Application, in USD Million
19. Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
20. Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
21. Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
25. Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
26. Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
1. Figure Adalimumab Biosimilar Industry Chain Structure
2. Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Adalimumab Biosimilar Market Growth 2016-2020, by Type, in Volume
4. Figure Global Adalimumab Biosimilar Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Adalimumab Biosimilar Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Adalimumab Biosimilar Market Concentration, in 2020
7. Figure Europe Adalimumab Biosimilar Market Market Concentration, in 2020
8. Figure Asia-Pacific Adalimumab Biosimilar MMarket Concentration, in 2020
9. Figure South America Adalimumab Biosimilar Market Concentration, in 2020
10. Figure Middle East & Africa Adalimumab Biosimilar Market Concentration, in 2020
11. Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in USD Million
12. Figure Adalimumab Biosimilar Demand in Hospital Pharmacy, 2016-2020, in Volume
13. Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in USD Million
14. Figure Adalimumab Biosimilar Demand in Retail Pharmacy, 2016-2020, in Volume
15. Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in USD Million
16. Figure Adalimumab Biosimilar Demand in Online Pharmacy, 2016-2020, in Volume
17. Figure Adalimumab Biosimilar Market Growth 2021-2026, by Application, in USD Million
18. Figure Adalimumab Biosimilar Market Share in 2026, by Application, in USD Million
19. Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
20. Figure North America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
21. Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
25. Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
26. Figure South America Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Adalimumab Biosimilar Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview
